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Background: Literature-based discovery (LBD) is characterized by uncovering hidden associations in non-
interacting scientiﬁc literature. Prior approaches to LBD include use of: (1) domain expertise and struc-
tured background knowledge to manually ﬁlter and explore the literature, (2) distributional statistics and
graph-theoretic measures to rank interesting connections, and (3) heuristics to help eliminate spurious
connections. However, manual approaches to LBD are not scalable and purely distributional approaches
may not be sufﬁcient to obtain insights into the meaning of poorly understood associations. While several
graph-based approaches have the potential to elucidate associations, their effectiveness has not been ful-
ly demonstrated. A considerable degree of a priori knowledge, heuristics, and manual ﬁltering is still
required.
Objectives: In this paper we implement and evaluate a context-driven, automatic subgraph creation
method that captures multifaceted complex associations between biomedical concepts to facilitate
LBD. Given a pair of concepts, our method automatically generates a ranked list of subgraphs, which pro-
vide informative and potentially unknown associations between such concepts.
Methods: To generate subgraphs, the set of all MEDLINE articles that contain either of the two speciﬁed
concepts (A, C) are ﬁrst collected. Then binary relationships or assertions, which are automatically
extracted from the MEDLINE articles, called semantic predications, are used to create a labeled directed
predications graph. In this predications graph, a path is represented as a sequence of semantic predica-
tions. The hierarchical agglomerative clustering (HAC) algorithm is then applied to cluster paths that
are bounded by the two concepts (A, C). HAC relies on implicit semantics captured through Medical
Subject Heading (MeSH) descriptors, and explicit semantics from the MeSH hierarchy, for clustering.
Paths that exceed a threshold of semantic relatedness are clustered into subgraphs based on their shared
context. Finally, the automatically generated clusters are provided as a ranked list of subgraphs.
Results: The subgraphs generated using this approach facilitated the rediscovery of 8 out of 9 existing sci-
entiﬁc discoveries. In particular, they directly (or indirectly) led to the recovery of several intermediates
(or B-concepts) between A- and C-terms, while also providing insights into the meaning of the
associations. Such meaning is derived from predicates between the concepts, as well as the provenance
of the semantic predications in MEDLINE. Additionally, by generating subgraphs on different thematic
dimensions (such as Cellular Activity, Pharmaceutical Treatment and Tissue Function), the approach may
enable a broader understanding of the nature of complex associations between concepts. Finally, in a
statistical evaluation to determine the interestingness of the subgraphs, it was observed that an arbitrary
association is mentioned in only approximately 4 articles in MEDLINE on average.
Conclusion: These results suggest that leveraging the implicit and explicit semantics provided by
manually assigned MeSH descriptors is an effective representation for capturing the underlying context
of complex associations, along multiple thematic dimensions in LBD situations.
Published by Elsevier Inc.
1 MeSH is a controlled vocabulary (or thesaurus) of biomedical terms, organized in
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Literature-based discovery (LBD) refers to the process of uncov-
ering hidden connections that are implicit in scientiﬁc literature.
Numerous hypotheses have been generated from scientiﬁc lit-
erature, using the LBD paradigm, which inﬂuenced innovations in
diagnosis, treatment, preventions, and overall public health.
The notion of LBD was proposed by Don R. Swanson (1924–2012)
in 1986, through the well-known Raynaud Syndrome–Dietary Fish
Oils Hypothesis (RS-DFO) [1]. By reading the titles of more than
4000 MEDLINE articles, Swanson serendipitously discovered
that Dietary Fish Oils (DFO) lower Blood Viscosity, reduce Platelet
Aggregation and inhibit Vascular Reactivity (speciﬁcally
Vasoconstriction). Concomitantly, he observed that a reduction in
both Blood Viscosity and Platelet Aggregation, aswell as the inhibition
of Vasoconstriction, appeared to prevent Raynaud Disease; a circula-
tory disorder that causes periods of severely restricted blood ﬂow to
the ﬁngers and toes [2]. Swanson therefore postulated that ‘‘dietary
ﬁsh oil might ameliorate or prevent Raynaud’s syndrome.’’ This
hypothesis was clinically conﬁrmed by DiGiacomo et al. [3] in 1989.
Swanson’s discovery is interesting because explicit associations
between DFO and these intermediate concepts (i.e., Blood Viscosity,
Platelet Aggregation and Vasoconstriction) had long existed in the
literature [4–8]. Likewise, explicit associations between the inter-
mediates and RS had been well documented [9,2]. The serendipity
in Swanson’s Hypothesis lies in the fact that no explicit asso-
ciations linking DFO and RS directly had been previously articulat-
ed in a single document.
To develop this hypothesis, Swanson performed a Dialog
Scisearch using Raynaud and Fish Oil terms, on titles and abstracts
of MEDLINE and Embase (Excepta Medica) citations, in November
1985. There were approximately 1000 articles in the Raynaud set
and 3000 in the Fish Oil set. He found that only four articles among
a reduced set of 489 articles (after ﬁltering), contained cross-refer-
ences spanning both sets. Among these four articles, only two arti-
cles [10,11] discussed relevant aspects of RS with DFO; although
not in the context of Swanson’s discovery. Swanson speculated
that this phenomenon of logically related but noninteracting lit-
eratures alludes to the existence of undiscovered public knowledge
[1]. Logically related information fragments may exist in the lit-
erature, but may have never been connected, or fully elucidated.
He subsequently exploited his awareness of the existence of such
undiscovered associations and investigated several other scenarios
(three with Smalheiser [12–14]) that later led to new scientiﬁc dis-
coveries [15,16]. Swanson grounded his observations in a paradigm
now commonly known as the ABC model [1] for LBD, which is an
integral part of LBD research, facilitating the generation of several
hypotheses [1,15,16,12–14,17–25].
In current biomedical research, while ﬁnding unknown inter-
mediates is an important task, domain scientists are often interest-
ed in developing a deeper understanding of causal relationships
and mechanisms of interaction among concepts. For example, con-
sider the complex scenario depicted in Fig. 1, in which Dietary Fish
Oils produce several Prostaglandins, including Prostaglandin I3
ðPGI3Þ and Epoprostenol ðPGI2, the synthetic form of ProstacyclinÞ.
The latter of these Prostaglandins (Epoprostenol)was known to treat
Raynaud Syndrome. It was also known to disrupt Platelet
Aggregation. Since Platelet Aggregation is deemed a cause of
Raynaud Syndrome, one can reasonably conclude that a plausible
mechanism by which Dietary Fish Oils treat Raynaud Syndrome is
through the production of Prostaglandins, which actively disrupt
Platelet Aggregation.
Aside from detecting such causal associations, it is known that
complex associations may exist between concepts, in many differ-
ent ways. For example, Fig. 2 shows that Dietary Fish Oils andRaynaud Syndrome are associated in at least the following three
ways: (1) in terms of Cellular Activity involving Blood platelets/
Prostaglandins, as shown in Fig. 2a, (2) through Pharmaceuticals that
contain calcium channel blockers, such as Nifedipine and Verapamil,
as shown in Fig. 2b, and (3) through Lipids/Fatty Acids from Efamol
and Evening primrose oil, as shown in Fig. 2c.
In this paper, we build on our previous approach [26], in which
we rediscovered and decomposed the Raynaud Syndrome – Dietary
Fish Oils discovery. In our previous work, we manually created the
multi-faceted subgraphs, by grouping together paths of semantic
predications. Recall that a semantic predication is a binary relation
between two concepts, expressed in the form (subject, predicate,
object). Here, we present a method that uses rich representations
to automatically create such subgraphs, by leveraging implicit
and explicit semantics provided by MeSH descriptors.1 To create
the subgraphs, we ﬁrst specify the context of a semantic predication
and then use it to infer the context of a path. Paths are then clustered
into coherent subgraphs on multiple thematic dimensions, based on
their shared context.
The approach requires only three items from the user as input:
(1) a list of concept labels for source (A) and target (C), (2) the max-
imum path length k of paths to be generated (default k ¼ 2, for ABC
associations), and (3) a cut-off date dt for articles to be included
from the scientiﬁc literature. If no cut-off date is provided then
all MEDLINE articles are used. The output of the approach is a
ranked list of subgraphs S – i.e., create a function F : q ! S, where
q ¼ A;C; dt; kf g.
To facilitate understanding the meaning of associations present
in the subgraphs, the predicates of the semantic predications and
their provenance in MEDLINE are provided (see Section 4).
Relationships that are not explicit in the subgraphs, but are
inferred, can be explored by composing MEDLINE queries (as we
will show). The collective use of predicates, provenance and
MEDLINE queries for knowledge exploration constitute the notion
of discovery browsing, introduced by Wilkowski et al. [27] and
extended by Cairelli et al. [28]. Discovery browsing is enabled
when a system guides the user through their exploration of the lit-
erature in a process of cooperative reciprocity. The ‘‘user iteratively
focuses system output, thus controlling the large number of relation-
ships often generated in literature-based discovery systems.’’
To assess the efﬁcacy of our approach, two forms of evaluation
were conducted: (1) an evidence-based evaluation and (2) a statis-
tical evaluation. The evidence-based evaluation showed that the
generated subgraphs could facilitate the rediscovery of 8 out of 9
existing discoveries [1,15,16,12–14,29,30] (not recovered [28]).
The statistical evaluation showed that an arbitrary association
occurs only in approximately 4 articles in MEDLINE on average.
This evaluation determines the interestingness of the subgraphs in
general, as a way to assess whether a domain scientist might be
interested in an arbitrary subgraph in the ﬁrst place (see in
Section 4.2). These results suggest that the subgraphs created using
our approach provide an effective way of ﬁnding and elucidating
poorly understood associations and may be of interest to domain
scientists. In this paper we make the following speciﬁc
contributions:
1. We develop a novel context-driven subgraph creation method
for closed LBD (both A and C are known), capable of ﬁnding
complex associations. Our approach is distinct from previous
approaches, which are mainly based on statistical frequency,
graph metrics, and speciﬁcity.a hierarchical structure – https://www.nlm.nih.gov/mesh/.
Fig. 1. Complex association between dietary ﬁsh oils and Raynaud syndrome.
Fig. 2. Thematic dimensions of association for Raynaud syndrome and dietary ﬁsh oil.
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matically create complex subgraphs using implicit and explicit
semantics, without the need for complex heuristics for ﬁltering.
3. We illustrate the role of discovery browsing, through the use of
predicates and provenance to supplement the subgraphs with
insights from the scientiﬁc literature.
4. We show the effectiveness of this approach in facilitating the
rediscovery of 8 out of 9 existing scientiﬁc discoveries.
The rest of this paper is organized as follows: related work is
covered in Section 2. The approach to automatic subgraph creation
is discussed in Section 3. Experimental Results are presented in
Section 4 and a thorough discussion on limitations and future work
are presented in Section 5. Conclusions are presented in Section 6.2. Related work
Leveraging rich representations of textual content from scien-
tiﬁc literature could be effective for ﬁnding and elucidating com-
plex associations. Rich representations exploit implicit, formal (or
explicit) and powerful semantics [31] to capture context, which
may be important in providing deeper insights into the nature of
associations. Gordon and Dumais made this crucial observation
in [32] after successfully applying the popular technique of
Latent Semantic Indexing (LSI) for LBD. The authors reported that
LSI was only slightly more effective than traditional frequency-
based metrics, such as token frequency, record frequency, and term
frequency-inverse global frequency (tf-igf) [33] for ﬁnding inter-
mediates. While LSI was successful for knowledge rediscovery,
the authors speculated that richer representations of textual con-
tent are needed to capture ‘‘evidence suggestive of ‘causal’ relation-
ships in the literature (which may be revealed independently of their
statistical prominence).’’ Moreover, they stressed the need for
‘‘semantic and category knowledge to improve the step of identifying
[intermediate and] terminal concepts.’’Many techniques for ﬁnding hidden connections (or asso-
ciations) between biomedical concepts from scientiﬁc literature
however, utilize frequency-based and graph-theoretic metrics.
Few methods have been developed to ‘seamlessly’ ﬁnd and eluci-
date complex associations, by going beyond reliance on implicit
semantics. Instead, the conventional wisdom has been that discov-
eries are likely to arise from logical connections between source
(A) concepts, intermediates (B) and targets (C) that frequently or
rarely (co) occur in the literature, or are highly or rarely connect-
ed in a knowledge base.
The earliest frequency-based approaches utilized ‘frequency of
occurrence’ mainly through measures of term (and concept) fre-
quency [34,17]. Other measures such as relative frequency, token
frequency, term frequency-inverse global frequency (tf-igf) [33],
and term frequency-inverse document frequency (tf-idf) [35,36]
were also used to rank intermediates. Subsequent approaches uti-
lized ‘frequency of co-occurrence’ using techniques such as LSI
[32], association rules [37–39,20], and probability distributions
[20,40,41,29]. Torvik et al. [40,42] even used an ensemble approach
to ﬁnd intermediates that combined statistical and temporal
features.
While distributional approaches have been successful for some
LBD situations, the underlying frequencies only provide an indirect
way of capturing the meaning of associations among concepts. For
instance, consider the association in which Dietary Fish Oils (A)
inhibit Platelet Aggregation (B) and the aggregation of blood plate-
lets causes Raynaud Disease (C). While Dietary Fish Oils, Platelet
Aggregation, and Raynaud Disease may frequently co-occur in the
literature, their precise association is not explicitly captured by
their co-occurrence. A second issue is that the underlying frequen-
cy distribution may not be adequate for capturing related concepts,
which may be important in elucidating causal relationships and
mechanisms of interaction.
To address these problems, several relations-based techniques
[19,22,43] have been developed, which use the explicit
2 SemRep – http://semrep.nlm.nih.gov/.
3 Obvio video demo - http://bit.ly/obviodemo, Obvio Project page - http://wiki.
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are typically obtained from structured background knowledge or
known a priori by domain experts. For example, Hristovski et al.
in [22], developed a relations-based approach that used ordered
alternating sequences of predicates and classes (or semantic types)
called discovery patterns. These patterns are speciﬁed a priori using
insights from background knowledge. Using discovery patterns,
Hristovski argues that if a Disease causes a change in a Substance/
Body Function and a Drug inhibits this change, then the Drug
MAYBE_TREATS the Disease. The CAUSES-INHIBITS sequence is used to
uncover potentially new Drug treatments for the Disease.
While intuitive, the relations-based approach is mainly applica-
ble in scenarios where both predicates and semantic types are
known, or can be easily obtained. This is not always trivial, as illus-
trated in the scenario from Fig. 1. Additionally, it can be argued that
hierarchical relations from the schema of a domain speciﬁc knowl-
edge base, such as the Uniﬁed Medical Language System (UMLS)
can also be used to create such complex subgraphs, using measures
like speciﬁcity. However, the semantic types for Prostaglandins and
Platelet Aggregation are Eicosanoids and Cell Function, respectively.
These semantic types share no common ancestors in their lineage
in the UMLS Semantic Network (https://uts.nlm.nih.gov/semantic-
network.html). And while associative relations can be used instead,
a proven and repeatable schema-driven approach that captures this
level of complexity has not been forthcoming.
Contemporary approaches to LBD focus on creating subgraphs,
which comprise of binary relations among concepts, called seman-
tic predications. These predications are extracted directly from
assertions in scientiﬁc literature, using SemRep [44]. Wilkowski
et al. [27] developed a graph-theoretic approach based on semantic
predications that iteratively (and manually) uses a greedy strategy
to create the ‘best’ subgraph, by weighting edges using degree cen-
trality. This approach was used to elucidate the association among
Norepinephrine, Depression, and Sleep.
Wilkowski’s approach is similar to the approach by
Ramakrishnan et al. [45], in which a greedy strategy is applied,
using an ensemble of features, to generate complex associations.
Ramakrishnan’s approach is fully automatic and uses class and
property speciﬁcity, instance-level rarity, and refraction to ﬁnd
hidden connections. However, this approach was used on a syn-
thetically generated dataset, instead of a real dataset consisting
of semantic predications. Ramakrishnan notes that this approach
was used, in exploratory research, to recover the connections from
the Raynaud Syndrome – Dietary Fish Oils discovery. However its
broader applicability for LBD in general has not been fully demon-
strated. Reliance on hierarchical relationships in the UMLS
Semantic Network is subject to inconsistencies since the UMLS is
a terminology and not a formal ontology. Also, by design, the trees
in the UMLS Semantic Network are fairly disjoint, as for
Prostaglandins and Platelet Aggregation.
Goodwin et al. [46] developed a hybrid approach that uses
spreading activation for LBD, deriving weights from relative fre-
quencies (of concepts and semantic predications) and degree cen-
trality. This approach was used to successfully recover the
intermediate Cortisol in the Testosterone – Sleep discovery [30],
and also to elucidate the Norepinephrine, Depression, and Sleep sce-
nario from [27]. However, Goodwin generates a list of intermedi-
ates instead of a graph. It is therefore unclear how the spreading
activation algorithm might be adapted to capture the context of
complex associations. In [47] van der Eijk et al. clustered only
MeSH descriptors (not semantic predications) into subgraphs,
based on frequency of co-occurrence and Hebbian Learning. This
approach provided new insights into the association between
Deafness and Macular Dystrophy, and between Insulin and Ferritin.
In recent work, Spangler et al. [48] also used distributionalstatistics (tf-idf) to weight edges in a kinase network, using graph
diffusion applied to a Laplacian Matrix. The approach creates an n-
ary similarity tree in which 7 new p53 kinases were discovered,
which could revolutionize Cancer treatments. The approach for
clustering of cliques developed by Zhang et al. [49,50] may be used
to capture subgraphs on multiple thematic dimensions. However,
the approach is based on degree centrality and is therefore more
likely to create subgraphs that only consist of highly connected
concepts from the literature.
In spite of the successes of and frequency-, relations-, and
graph-based approaches to LBD, more effective methods for cap-
turing the context of associations are desired. Gordon and
Dumais suggested a possible independence between frequency
and causality for LBD in [32]. We believe that complex associations
that elucidate the relationships among concepts depend both on
implicit and explicit context. Further, we believe that capturing
such context may be the important in segregating complex asso-
ciations along multiple thematic dimensions. In this paper, we
explore the idea that hidden connections, and their related con-
cepts, which help elucidate underlying complex associations,
are more dependent on context than frequency, connectivity
or speciﬁcity. In the next section, the approach for automatic sub-
graph creation based on this premise is presented.3. Approach
To automatically create complex subgraphs our approach relies
on three datasets. The ﬁrst dataset isMEDLINE,which is a repository
of more than 23 million bibliographic citations maintained by the
National Library of Medicine (NLM). The second is SemMedDB
[51], a database of more than 65 million semantic predications
extracted fromMEDLINE. Semantic predications are extracted using
a tool called SemRep,2 developed at NLM. The third is the Biomedical
Knowledge Repository (BKR), a knowledge base consisting of state-
ments from the UMLS Metathesaurus together with semantic
predications extracted using SemRep. These datasets are used for
automatic subgraph creation in ﬁve steps: (1) Query Speciﬁcation,
(2) Candidate Graph Generation, (3) Path Context Representation,
(4) Path Clustering, and (5) Subgraph Ranking. Each step is discussed
in the following subsections, and also outlined in Algorithm 1:
Algorithm 1. autoSubGen(Set A, Set C, Integer k, Date dt)
1: D :¼ getPMIDs(A; dt) [ getPMIDs(C; dt)
2: S :¼ empty, G :¼ empty, R :¼ empty
3: for all pmids d 2 D do
4: tðdÞ :¼ getPreds(d)
5: G:addðtðdÞÞ
6: end for
7: for all concept pairs ða; cÞ 2 A C do
8: p :¼ getPaths(a; c; k;G)
9: R:addðpÞ
10: end for
11: S = rankClusters(getClusters(R))3.1. Query speciﬁcation
The system (called Obvio,3 see Appendix A) ﬁrst requires a query,
denoted q, which can be speciﬁed initially by providing the labels ofknoesis.org/index.php/Obvio.
Fig. 3. System architecture.
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concept unique identiﬁers (or CUIs), using the UMLS Semantic
Navigator.4 For example, the A-term Dietary Fish Oil, maps to the
UMLS concept C0016157, whose label is also Fish Oils. Initial A- and
C-terms are also manually augmented with other closely related
concepts. For example, the concepts Fish oil – dietary (C0016157)
and Eicosapentaenoic Acid (C0000545) are closely related to Fish Oils
(C0016157) and are therefore added to the query. Next, the cut-off
date dt for the literature to be included may be optionally provided.
If no cut-off date is given the system uses the entire MEDLINE data-
base. The maximum path length k, of paths to be generated between
A and C may then also be optionally provided. If none is given, the
system defaults to a maximum path length of k ¼ 2. An example
query for Raynaud Syndrome – Dietary Fish Oils is as follows: q =
({Fish Oils, Fish oil – dietary, Eicosapentaenoic Acid}, {Raynaud
Phenomenon, Raynaud Disease}, 11/01/1985, 3). In plain English, ‘get
me all subgraphs between dietary ﬁsh oils and raynaud syndrome,
using scientiﬁc literature published before November 1985, and con-
sisting of paths up to length 3.’3.2. Candidate graph generation
Given a query q ¼ ðA;C; dt; kÞ, the Query Processor (Fig. 3, top
center) then retrieves the set of MEDLINE documents D that
contain any of the terms (i.e., labels) in the A- and C- sets
(Algorithm 1, line 1). These documents form the corpus fromwhich
semantic predications will subsequently be obtained. To obtain the
predications, the set of PubMed identiﬁers (or PMIDs) for each arti-
cle in D is processed by the Predications Graph Builder (Fig. 3, mid-
dle center), which creates a labeled directed predications graph,
denoted G. To achieve this, the graph builder collects the semantic
predications for each document in D that are also present in
SemMedDB5 (Algorithm 1, line 4). The graph builder then creates
a predications graph (Algorithm 1, line 5) in which nodes are
UMLS concepts and edges are UMLS predicates. This graph is deliv-
ered as input to the Subgraph Generator (Fig. 3, bottom center), which
ﬁrst uses the Path Generator to extract all paths between (A, C) up to
length k, using the Depth First Search (DFS) algorithm (Algorithm 1,
line 8). DFS is selected because both A and C are known. However,
the choice of Breadth First Search (BFS) may be equally effective
for graph traversal, but has not been explored, since performance
is not the primary focus at this point. Using DFS, the path generator
effectively uses the predications graph to produce paths (or q-path
associations from [52]), except that edges are oriented in either
direction, as we previously noted in [26]. This restricted set of paths
is called the reachability relation R [53] (or candidate graph) between
A and C at length k, and date range dt. This candidate graph repre-
sents a more likely set from which discoveries will arise.3.3. Path context representation
The candidate graph is provided as input to the Path Clustering
Module (Fig. 3, bottom center), which requires a deﬁnition for the
context of a path p to cluster related paths into subgraphs. To spe-
cify path context, denoted CðpÞ, we ﬁrst specify the context of a
semantic predication t, denoted cðtÞ. The context of each predica-
tion in the path is then aggregated to obtain overall path context.
To deﬁne the context of a semantic predication, we make two
assumptions, based on observations about MEDLINE articles. The
ﬁrst observation is that MeSH descriptors are manually assigned
to MEDLINE articles (titles and abstract only) by MeSH indexers,
based on human interpretation of the meaning of the entire article.4 Semantic Navigator – http://mor2.nlm.nih.gov:8000/perl/auth/semnav.pl.
5 SemMedDB – http://skr3.nlm.nih.gov/SemMedDB/.These descriptors provide a concept-level semantic summary of the
full text. Similarly, semantic predications also provide a semantic
summary of the meaning of the content. However, semantic
predications provide a relational semantic summary, by linking con-
cepts using explicit predicates.
We therefore assume that the MeSH descriptors and the seman-
tic predications of an article capture its implicit context. This con-
text is shared across the two abstractions of the meaning of the
content. A semantic predication may therefore be represented in
terms of the MeSH descriptors assigned to the article in which
the predication occurs. This is the basis for our interchangeability
assumption for subgraph creation, which states that the concept-
level semantic summary and relational semantic summary of a
MEDLINE article, are interchangeable. More speciﬁcally, given a
semantic predication t and a MEDLINE article d such that t is
extracted from d, the context of the semantic predication
cðtÞ ¼ MðdÞ, where MðdÞ is the set of MeSH descriptors assigned
to d. Likewise, the context of a MeSH descriptor m, denoted cðmÞ,
is the set of semantic predications TðdÞ, assigned to the article d
in which m occurs (i.e., cðmÞ = TðdÞ).
If this assumption holds, then we can make a second assump-
tion, which is that the implicit context of a semantic predication
t across the entire corpus can be represented as a vector of MeSH
descriptors aggregated from each document containing t (based
on distributional semantics). This is the basis for our context dis-
tribution assumption for subgraph creation, which states that the
implicit context of a semantic predication can be expressed as the dis-
tribution of all MeSH descriptors associated with all articles in which
the predication occurs.
Since our fundamental premise for subgraph creation is that
relatedness among concepts is independent of statistical frequency
(as noted by Gordon and Dumais [32]), graph metrics or speciﬁcity,
our vector representation is downgraded to the Boolean-valued set
representation (i.e., the equivalent of a binary vector), in which a
MeSH descriptor is either present or absent in the distribution.
The context of a path
CðpÞ ¼
[
t2p
cðtÞ ð1Þ
is therefore the aggregation of its predication context sets.3.4. Path clustering
ThePathClusteringModuleuses the context set CðpÞ for eachpathp
in the candidate graph R to cluster related paths pi and pj, based on
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the system initially computes the intersection s00ðpi; pjÞ ¼
CðpiÞ \ CðpjÞ of their shared MeSH descriptors. However, to account
for inexact matches between MeSH descriptors across the two sets,
this intersection is enhanced using the MeSH hierarchy, which pro-
vides explicit (or formal) semantics. Speciﬁcally, we use the
Cartesian product of the two context sets CðpiÞ  CðpjÞ to determine
which pairs of MeSH descriptors adequately indicate relatedness
between the paths. Pairs of descriptors ðmi;mjÞ, whose similarity is
above some threshold of MeSH semantic similarity are retained,
while those below are discarded. The key idea is to maximize the
weights of the in-context descriptors and minimize the weights of
the out-of-context descriptors.
To compute semantic similarity between MeSH descriptors the
measure of dice similarity is used. Dice similarity computes the pro-
portion of common ancestors between descriptors in the MeSH
hierarchy (MH). For two MeSH terms mi and mj the dice similarity
is computed as
diceðmi;mjÞ ¼ 2
jancestorsðmiÞMH \ ancestorsðmjÞMHj
jancestorsðmiÞMHj þ jancestorsðmjÞMHj
; ð2Þ
where ancestorsðmiÞMH is the set of all ancestors of mi in MeSH. The
maximum similarity between two descriptors computed using dice
similarity is 1. This maximum value occurs when the descriptors are
equal. (i.e., mi ¼ mj). The range of similarity values is [0, 1].
In this computation, pairs of descriptors, whose dice similarity
exceed the threshold of semantic similarity (manually assigned
as ssim ¼ 0:75) are normalized to a value of 1. This normalized dice
similarity
diceNðmi;mjÞ ¼
1 if diceðmi;mjÞ > ssim
0 otherwise

ð3Þ
is therefore computed conditionally. The initial overall semantic
relatedness
sr00ðpi; pjÞ ¼
X
ða;bÞ2CðpiÞCðpjÞ
diceNða; bÞ ð4Þ
between pi and pj is the sum of the normalized pairwise dice simi-
larity scores that exceed the threshold of semantic similarity, across
the Cartesian Product of the context sets CðpiÞ  CðpjÞ.
A consequence of this semantics-enhanced shared contextmetric,
is that a broad range of relatedness scores may exist. Paths that are
very similar, which have many exact (and inexact) MeSH descrip-
tors in common will have very scores, while others may have low
scores. To dampen the major differences in similarity scores of dif-
ferent path pairs, we apply a log reduction on the normalized dice
similarity scores. This is achieved by ﬁrst computing the related-
ness score between a given MeSH descriptor a in context set
CðpiÞ against the entire set of descriptors in the context set CðpjÞ.
This computation yields the similarity score
sim0ða;CðpjÞÞ ¼
X
b2CðpjÞ
diceNða; bÞ: ð5Þ
The log reduction
sr00Lðpi; pjÞ ¼
X
a2CðpiÞ
log 1þ sim0ða;CðpjÞÞ
  ð6Þ
is then applied to sim0ða; CðpjÞÞ, and the overall semantic relatedness
between the two paths is the aggregate of the log-reduced scores
for each descriptor in CðpiÞ and the entire set in CðpjÞ. This metric
sr00Lðpi;pjÞ, is our basis for ﬁnding and elucidating complex asso-
ciations among concepts, along multiple thematic dimensions,
based on implicit and explicit semantics, alluded to by Gordon
and Dumais in [32].In the next step the hierarchical agglomerative clustering (HAC)
algorithm is used to create subgraphs by clustering related paths
(Algorithm 1, line 11, getClusters(R)). In the bucket population step,
the algorithm initializes jRj buckets, one for each path in the candi-
date graph. For a given path, the relatedness score is computed for
each of the remaining jRj  1 paths. If two paths are sufﬁciently
related, they must be placed in the same cluster. To achieve this,
a method to automatically determine the threshold for path relat-
edness denoted srel, is required.
To obtain the threshold for path relatedness the distribution of
path relatedness scores between all pairs of paths in the candidate
graph was pre-computed (i.e., ðjRj  jR 1jÞ=2 scores). Fig. 4 shows
the distribution of relatedness scores for three experiments in the
initial stages of our research. Each distribution approximates to a
Gaussian (or normal) distribution.
In statistics, the ﬁrst standard deviation ðr;þrÞ from the
mean of a Gaussian distribution corresponds to the point of inﬂec-
tion. This point likely indicates a shift in a trend or phenomenon.
When the manually determined thresholds for path relatedness
for the same three experiments were compared to the r;2r, and
3r of the Gaussian distribution, it was observed that the manual
thresholds were consistently between the 2r and 3r, as shown
in Table 1. The second deviation from the mean of the Gaussian
distribution (srel ¼ 2r) was therefore selected as the path related-
ness threshold for clustering. During clustering, all pairs of paths
with relatedness scores above this automatically determined
threshold were added to the same cluster.
In the next phase of HAC (bucket merging), buckets that contain
multiple paths were merged if their inter-cluster similarity exceed-
ed the threshold for path relatedness. That is, for each pair of paths
ðpi; pjÞ across a pair of buckets Ba and Bb, the inter-cluster similarity
siminterðBa;BbÞ ¼
P
ðpi ;pjÞ2BaBb sr
00
Lðpi; pjÞ
jBaj  jBbj ; ð7Þ
was computed as the sum of the semantic relatedness scores, nor-
malized by the sizes of the two buckets. The clustering algorithm
terminated when the number of clusters between successive itera-
tions remained unchanged.
3.5. Subgraph ranking
The generated subgraphs were then ranked (Algorithm 1, line
11, rankClusters(S0)) – where S0 is the unranked list of subgraphs
from getClustersðRÞ. Subgraphs containing more than one path are
ranked in descending order, based on their intra-cluster similarity,
which measures the compactness of the cluster. To compute this
measure
simintraðBÞ ¼
2 Ppi ;pj2B; pi–pj sr00Lðpi; pjÞ
jBj  ðjBj  1Þ ; ð8Þ
the aggregate of the relatedness score for each pair of paths ðpi – pjÞ
in a given cluster B is obtained and then normalized.
Singleton clusters consisting of only one path are ranked in
ascending order using the measure of association rarity. Given a
path pi, we deﬁne an association AðpiÞ as the set of unique concepts
in the path. Association rarity is therefore the number of MEDLINE
articles f ðAðpiÞÞ that contain only the concepts in the path. For sin-
gleton buckets, bucket rarity
rðBÞ ¼
P
pi2Bf ðAðpiÞÞ
jBj ð9Þ
is the same as association rarity, since B ¼ pif g and jBj ¼ 1. The
ranked list of clusters is rendered to the user for inspection in the
Discovery Browsing Interface (Fig. 3, middle left). This interface is
shown in Appendix A and also available online (live tool – http://
Fig. 4. Gaussian distribution of path relatedness scores for three rediscovery
scenarios.
D. Cameron et al. / Journal of Biomedical Informatics 54 (2015) 141–157 147knoesis-hpco.cs.wright.edu/obvio/, video demo – http://bit.ly/ob-
viodemo). Concepts are color-coded based on semantic groups
obtained from the BKR, while predicates are color-coded based on
a locally developed coding scheme, since none exists for predicates
in the BKR.
Using this approach, 8 out of 9 existing scientiﬁcdiscoverieswere
recovered. These well-known discoveries are: (1) Raynaud – Fish Oil
(1986) [1], (2)Magnesium –Migraine (1988) [15], (3) Somatomedin C
– Arginine (1990) [16], (4) Indomethacin – Alzheimer’s Disease (1996)
[12], (5) Estrogen – Alzheimer’s Disease (1996) [13] (6) Calcium-
Independent Phospholipase A2 – Schizophrenia (1998) [14], (7)
Chlorpromazine – Cardiac Hypertrophy (2004) [29], (8) Testosterone
– Sleep (2012) [30] and (9) Diethylhexyl (DEHP) – Sepsis (2013)
[28]. In the next section the application of this approach for the
rediscoveries is discussed.
4. Experimental results
Given the absence of a gold standard dataset in LBD research,
knowledge rediscovery is considered a de facto standard for
evaluating LBD systems. To assess the effectiveness of our con-
text-driven subgraph method, both an evidence-based evaluation
and a statistical evaluation were conducted. The evidence-based
evaluation qualitatively determines the extent to which our
approach is capable of rediscovering the known knowledge, while
the statistical evaluation is intended to measure the likelihood that
a domain expert might be motivated to explore an arbitrary sub-
graph generated by the system. The latter achieves this by measur-
ing the ‘interestingness’ of a subgraph, by quantifying the rarity of
its associations in MEDLINE. Associations that have never been
mentioned in any MEDLINE article are considered rare and most
interesting. These are called zero-rarity associations (ZR). The obvi-
ous caveat is that rare associations are not necessarily all interest-
ing. The next section discusses the evidence-based evaluation.
4.1. Evidence-based evaluation
The ﬁrst aspect of the evidence-based evaluation reports on the
number of intermediates from a discovery that could be retrievedTable 1
Threshold comparisons.
Scenario Path relatedness scores Max
2 Std. dev. Manual 3 Std. dev.
Raynaud – ﬁsh oil 2.68 3.0 3.04 3.38
Testosterone – sleep 3.35 3.5 3.83 6.22
DEHP – sepsis 3.94 4.0 4.53 4.84by our system. The second aspect substantiates the meaning of
each association using evidence from the literature. Such evidence
can be derived ﬁrst using the predicates of the semantic predica-
tions in the subgraph. When this is insufﬁcient or contradictory,
evidence can be obtained using the provenance of the predications
in MEDLINE. Additionally, queries can be composed and executed
in PubMed6 to explore inferred associations, not explicitly stated
in the subgraphs, as commonly practiced.
For each rediscovery scenario, no concept ﬁlters were speciﬁed
to exclude concepts based on semantic types or groups. A generic
predicate ﬁlter, called the STRICT ﬁlter was applied uniformly by
the system (not the user), across some experiments, to exclude less
informative UMLS predicates, such as ASSOCIATED_WITH, INTERACTS_WITH,
and AFFECTS. This limited degree of manual ﬁltering is the extent of a
priori knowledge required for subgraph generation in the system.
Due to space limitations, only three experiments are discussed
in detail: (1) Raynaud – Fish Oil, (2) Magnesium – Migraine and (3)
Somatomedin C – Arginine. The six remaining experiments are dis-
cussed brieﬂy in Section 4.1.4. Further details on each experiment
are available in [54] and in the following online supplementary
materials: (1) the Obvio wiki page – (http://wiki.knoesis.org/in-
dex.php/Obvio, section on Automatic Subgraph Creation), (2) a
video demo – http://bit.ly/obviodemo and (3) a beta-version of
the Obvio web application – http://knoesis-hpco.cs.wright.edu/ob-
vio/. Also note that in the following tables, the letter Y (for yes) is
used to indicate that the status S of an intermediate as ‘found
directly in a subgraph’ at position P in the list of subgraphs. The
symbol Y indicates that an intermediate was found through dis-
covery browsing. The next section discusses the application of
our approach to the Raynaud – Fish Oil discovery.4.1.1. Raynaud syndrome – dietary ﬁsh oils
In November 1985, American Information Scientist Don R.
Swanson (1924 – 2012) explored the research question of the role
of Dietary Fish Oils (from salmon, mackerel, albacore, etc.) in
Raynaud Syndrome. Through the methods described in [1],
Swanson discovered that ‘‘dietary ﬁsh oil might ameliorate or pre-
vent Raynaud’s syndrome.’’ This is because Dietary Fish Oils: (1) inhi-
bit Platelet Aggregation, (2) increase the ﬂow of blood (by reducing
Blood Viscosity), and (3) also have a regulatory effect on the smooth
muscle (thereby preventing Vasoconstriction and stimulating
Vasodilation). Each of these concepts is causally implicated in
Raynaud.
We seeded our algorithm with three concepts as sources: (1)
Fish Oils (C0016157), (2) Fish oil – dietary (C0556145), and (3)
Eicosapentaenoic Acid (C0000545), and two concepts as targets:
(1) Raynaud Disease (C0034734) and (2) Raynaud Phenomenon
(C0034735). The corpus consisted of the relevant 61 full text arti-
cles discussed by Swanson [1] in the pre-November 1985 period.
There were only 4 articles from the Dietary Fish Oil set, which were
in the Raynaud set. The path length was set to 3 and no predicate
ﬁlter was speciﬁed. These choices are consistent with the choices
in our earlier experiments in [26], in which we rediscovered and
decomposed this hypothesis by manually constructing the sub-
graphs, using domain expertise as context.
The algorithm terminated in less than 5 min (on a 64-bit Linux
Virtual Machine, 8 Intel 2.4 GHz processors, 32 GB RAM, and 1.5 TB
hard drive), producing 4 subgraphs (and 134 singletons) at 2r and
one subgraph (and 164 singletons) at 3r. There were 1035 unique
concepts and 4143 unique predications in the predications graph
and the candidate graph contained 171 paths of length 3. Fig. 5
shows that at 3r, subgraph1 (the only subgraph produced) directly
contains the intermediate Platelet Aggregation, which many6 PubMed – http://www.ncbi.nlm.nih.gov/pubmed.
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covery. However, to better substantiate the association, we utilize
the predicates in the subgraph, together with the provenance of
the predications in MEDLINE, along with traditional PubMed
search, to provide evidence.
The predication which states that [Eicosapentaenoic Acid
CONVERTS_TO Prostaglandins] was extracted from the following
corroborating sentence, in the full text of the following article
[PMID6827988] by Harris et al. The authors state that the ‘‘recent
discovery that the prostaglandins derived from eicosapentaenoic acid
have biological effects different than those derived from arachidonic
acid (C20:4w6) has generated further interest in ﬁsh oils.’’ Two of
the other 61 articles [PMID6321621, PMID6314583] contained this
predication. Harris also refers to the 1979 article [PMID218223] by
Needleman et al., which suggests further that [Eicosapentaenoic
Acid CONVERTS_TO Prostaglandin ðPGI3Þ] in its metabolic pathway.
And the full text of 1985 article [PMID2997286] by von Schaky
et al. conﬁrms that Eicosapentaenoic Acid produces Prostaglandin
ðPGI3Þ and Epoprostenol (Prostacyclin ðPGI2Þ). von Schaky notes that
‘‘dietary EPA is transformed in vivo in humans into prostaglandins I3,
which is as active . . .as the vasodilatory and antiaggregatory
prostaglandin I2.’’
The subgraph also contains the predication which states that
[Eicosapentaenoic Acid DISRUPTS Platelet Aggregation]. This predica-
tion was extracted from the full text of the article [PMID6320840]
by Saynor et al., who refers to the ‘‘Mechanisms underlying the inhi-
bition of platelet aggregation by eicosapentaenoic acid and its metabo-
lites.’’ The predication [Alprostadil DISRUPTS Platelet Aggregation]
was extracted from the full text of the article [PMID6302714] by
Dyerberg et al., who pointed out that another author7 ‘‘was the ﬁrst
to show that [Prostaglandin E1] PGE1 inhibited platelet aggregation.’’
The previously mentioned article by von Schaky also alludes to this
point.
Conversely, the predication [Epoprostenol TREATS Raynaud’s
Phenomenon] was correctly extracted from two articles; by Dowd
et al. [PMID7037038], who discusses ‘‘Treatment of Raynaud’s phe-
nomenon by intravenous infusion of prostacyclin ðPGI2Þ’’ and by
Belch et al. [PMID3883365], who discusses ‘‘Increased prostacyclin
metabolites and decreased red cell deformability in patients with sys-
temic sclerosis and Raynauds syndrome.’’ Since both Alprostadil
ðPGE1Þ and Epoprostenol ðPGI2Þ are synthetic forms of
Prostaglandins, it is plausible that both Alprostadil and
Epoprostenol actually treat Raynaud’s Syndrome by disrupting
Platelet Aggregation. Indeed, the 1982 article [PMID6890719] by
Pardy et al., obtained through a date-restricted MEDLINE query,8
conﬁrms that Alprostadil ðPGE1Þ treats Raynaud Phenomenon, instead
of the weaker INTERACTS_WITH relationship, present in the subgraph.
The role of Platelet Aggregation in causing Raynaud, which is inferred
and not explicit in the subgraph, is easily conﬁrmed using another
MEDLINE query (Platelet Aggregation AND Raynaud AND 1865:1985/
11[DP]), which yields the 1985 article [PMID3985417] by Soro et al.
This subgraph together with discovery browsing suggest a
richer relationship among Eicosapentaenoic Acid, Platelet
Aggregation, and Raynaud Syndrome than would be provided by
their co-occurrence. Rather, it appears that one mechanism by
which [Eicosapentaenoic Acid TREATS Raynaud Syndrome] is by
stimulating a series of Prostaglandins (namely, Prostaglandin I3
ðPGI3Þ, Prostaglandin E1ðPGE1Þ, and Prostacyclin ðPGI2Þ), which actu-
ally disrupt Platelet Aggregation. This observation was ﬁrst
articulated by Swanson in [1].7 Kloeze, J. Prostaglandins, Proceedings of the 2nd Nobel Symposium, pp. 241–252
(BERTSTR(iM, S. and SAMUELSON, B., eds.) Almqvist and Wiksell, Stockholm, 1967).
8 Query: Alprostadil AND Raynaud AND 1865:1985/11[DP]. Conﬁrmed in search result
#12.An important observation is that the subgraph contains contra-
dicting semantic predications. For example, the two predications
[Eicosapentaenoic Acid CONVERTS_TO Prostaglandins] and
[Eicosapentaenoic Acid INHIBITS Prostaglandins] are opposing. The
full text of the article [PMID6827988] by Harris et al., from which
the predication [Eicosapentaenoic Acid CONVERTS_TO
Prostaglandins] was extracted supports its claim. However, the full
text of the lone article [PMID6301111] by Moncada fromwhich the
predication [Eicosapentaenoic Acid INHIBITS Prostaglandins] was
extracted states that ‘‘It is clear, therefore, that both prostaglandin
dependent and independent pathways of platelet aggregation are
inhibited by EPA in vitro.’’ This is an incorrect extraction from
SemRep. The author is noting that [Eicosapentaenoic Acid INHIBITS
Platelet Aggregation], not Prostaglandins as the predication suggests.
It is important to note that resolution of such discrepancies is part
of the discovery browsing process, which requires adjudication by
domain experts. We provide the infrastructure for achieving this
through provenance.
The second intermediate Blood Viscosity, was found in the list of
zero-rarity singletons (result #15 in Table 2). The actual singleton,
which states that [Eicosapentaenoic Acid DISRUPTS Blood Viscosity],
[Ketanserin DISRUPTS Blood Viscosity], [Ketanserin TREATS Raynaud
Disease], suggests a causal relationship between Blood Viscosity
and Raynaud Syndrome. This inferred relation that [Blood Viscosity
CAUSES Raynaud Syndrome] is conﬁrmed in the 1984 article
[PMID6707529] by Larcan et al. through a MEDLINE search.
The statement [Ketanserin DISRUPTS Blood Viscosity] is veriﬁed in
the following articles [PMID401574], [PMID6303363] and
[PMID2412054]. Likewise, the predication [Ketanserin TREATS
Raynaud Disease] can be veriﬁed in the article [PMID6432198] by
Roald et al. and also [PMID6209510] by Bounameaux et al.
Table 2 shows the number of intermediates rediscovered for
this experiment compared with 4 other approaches. The interme-
diate Vascular Reactivity (in reference to Vasoconstriction) was not
found explicitly by our approach (although can be inferred from
the article [PMID2997286] by von Schacky et al.). This result is
not completely unexpected, since it is known from our reports in
[26] that SemRep interprets ‘‘Vascular’’ and ‘‘Reactivity’’ as separate
concepts. Hristovski in [22] was also subject to the same limitation.
Srinivasan [36] found all three intermediates in the top 2 of the
top 30. However, note that Srinivasan’s approach relies on a priori
knowledge of the semantic types of the intermediates for ﬁltering
and is manually intensive. Additionally, that approach does not
create complex subgraphs, nor does it provide evidence for the
meaning of associations using predicates. Hristovski et al. [22]
and Weeber et al. [34] also require considerable domain expertise,
particularly for speciﬁcation of a priori relations (i.e., semantic
types and discovery patterns). Gordon and Lindsay [35] ﬁnd inter-
mediates but make no attempt to elucidate the meaning of the
associations.
To illustrate that our subgraphs capture different thematic
dimensions of association between two concepts, consider the four
subgraphs using srel ¼ 2r as the threshold for clustering.
Subgraph1 in Fig. 6a is similar to subgraph1 (at 3r) except that
it includes the three additional intermediates, TIMP1, TIMP1 pro-
tein, human, and Thromboembolism. This is naturally due to a lower
threshold for path relatedness. By inspection, this subgraph eluci-
dates the association between Dietary Fish Oils and Raynaud
Syndrome through Blood Platelets/Prostaglandins, similar to the pre-
vious subgraph.
Subgraph2 (shown in Fig. 7) associates Dietary Fish Oils and
Raynaud Syndrome from the perspective of Pharmaceuticals, includ-
ing Nifedipine, Pentifylline, Thyrocalcitonin, and Trinitrin detailed
especially in the article [PMID6352267] by Kahan et al., from
which the predication [Nifedipine TREATS Raynaud Phenomenon]
was extracted.
Fig. 5. Subgraph1 ðk ¼ 3;3rÞ on eicosapentaenoic acid, platelet aggregation and Raynaud syndrome.
Table 2
Comparison of rediscoveries with other approaches for Raynaud syndrome – dietary ﬁsh oils.
Scenario Intermediate(s) Cameron Srinivasan [7] Weeber [4] Gordon [3] Hristovski [17]
S P S P S P S P S P
Raynaud syndrome – dietary ﬁsh oils Blood viscosity Y⁄ ZR-15 Y 2 Y – Y 5 Y 8
Platelet aggregation Y 1 Y 1 Y – Y 6 Y 17
Vascular reactivity – – Y 1 Y – Y 19 – –
Fig. 6. Subgraph1 ðk ¼ 3;2rÞ on dietary ﬁsh oils – Raynaud syndrome (blood platelets/prostaglandins).
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which associate TIMP1, Epoprostenol, Efamol and Evening Primrose
(see [PMID4082084, PMID6318123, PMID6321621]).
Subgraph4 in Fig. 9, which focuses more on Cellular Activity at
the level of Blood Platelets involving Thromboembolism, is sub-
sumed by subgraph1. Currently, subgraph subsumption has not
been addressed in this work and remains a system limitation, dis-
cussed in Section 5. In the next section, the Migraine - Migraine
experiment is discussed.
4.1.2. Magnesium – Migraine
In August 1987, Swanson explored the research question of the
role of Magnesium in Migraine Disorder. Through the methods
described in [15] he discovered 11 neglected connections between
Magnesium and Migraine. He found that Magnesium deﬁciency
might exacerbate Migraine due to complications involving Stress
(Type A personality), Spreading Cortical Depression, Epilepsy, Platelet
Aggregation, Serotonin, Substance P, Inﬂammation, Vasoconstriction,
Prostaglandin formation, and Hypoxia. Also, as a natural calcium
channel blocker, Magnesium may prevent Migraine attacks.
We seeded our algorithm with Magnesium (C0024467) as the
source and Migraine Disorders (C0149931) as the target. The path
length was set to 2 and no predicate ﬁlter was used, to be more
consistent with the discovery. The corpus consisted of more than47,000 articles from the pre-August 1987 period (i.e., 41,507
abstracts on Magnesium and 6,171 on Migraine, 7 overlapping).
There were 14697 unique concepts, 73,960 predications in the
predications graph and 256 distinct paths of length 2 in the candi-
date graph. The algorithm terminated in less than one hour, pro-
ducing 25 subgraphs (and 151 singletons) at 2r and 6 subgraphs
(and 231 singletons) at 3r.
With regards to Serotonin, it was known from the 1973 article
[PMID4725298] by Vosgeru (one of the 7 overlapping) that
Magnesium Glutamate was used to treat Migraine. Fig. 10 shows
that the intermediate Serotonin was found in subgraph1 at 2r.
The lone article [PMID3629724] by Pertseva et al. from which
the predication [Magnesium INTERACTS_WITH Serotonin] was
extracted, is inconclusive. According to Swanson, [Magnesium
INHIBITS Serotonin]. The article [PMID3512233] by Houston et al.
from which the predication [Serotonin CAUSES Migraine] was
extracted (among three others), suggested that elevated levels of
Serotonin can induce Vasoconstriction, which causes Migraine.
Houston explicitly states that ‘‘much evidence has implicated sero-
tonin (5-hydroxytryptamine) in the pathogenesis of migraine.’’ The
article further notes that Serotonin is released from Platelet
Aggregation and might reach sufﬁcient levels to exacerbate
Migraine, as noted by Swanson. The 1987 article [PMID2440758]
by Briel et al. (through a MEDLINE search) conﬁrms that
Fig. 7. Subgraph2 ðk ¼ 3;2rÞ on dietary ﬁsh oils – Raynaud syndrome (pharmaceuticals).
Fig. 8. Subgraph3 ðk ¼ 3;2rÞ on dietary ﬁsh oils – Raynaud syndrome (lipids/fatty acids).
Fig. 9. Subgraph4 ðk ¼ 3;2rÞ on eicosapentaenoic acid, platelet aggregation and Raynaud syndrome (blood platelets).
Fig. 10. Subgraph1 ðk ¼ 2;2rÞ magnesium – migraine.
150 D. Cameron et al. / Journal of Biomedical Informatics 54 (2015) 141–157Magnesium inhibits Platelet Aggregation. It follows that elevated
Magnesium levels may inhibit both Serotonin and Platelet
Aggregation, and so treat Migraine.
Fig. 11 shows subgraph4, which contains the intermediate
Prostaglandins between Magnesium and Migraine. The lone article
[PMID3871957] by Friedlander et al. from which the predication
[Prostaglandins INTERACTS_WITH Magnesium] was extracted, sug-
gested that a decrease in prostaglandin synthesis is accompanied
by lower levels of magnesium (and calcium). This conclusion isbased on the title: ‘‘Decreased calcium and magnesium urinary excre-
tion during prostaglandin synthesis inhibition in the rat’’ as noted by
Swanson. The 1986 article [PMID3016750] by Nigam et al. con-
ﬁrms that [Magnesium STIMULATES Prostaglandins] as suggested
by Swanson. The article [PMID89390] by Hakkarainen et al. from
which the predication [Prostaglandins ASSOCIATED_WITH Migraine
Disorders] was extracted (among only three others) states that
‘‘Tolfenamic acid (a potent inhibitor of prostaglandin biosynthesis)
was effective in treating acute migraine attacks.’’ The speciﬁc role
of Prostaglandins in Migraine was unclear however, even after dis-
covery browsing. Swanson suggested that [Prostaglandins
INHIBITS Migraine].
Fig. 12 shows that the intermediate Vascular Disease was found
explicitly in subgraph9. The title of the article [PMID4260015] by
Wustenberg et al. from which the predication [Magnesium
ASSOCIATED_WITH Vascular Disease] was extracted, suggests a role
for magnesium in vascular reactivity. The title of the article reads
in part, ‘‘. . .Findings in magnesium metabolism in vascular diseases.’’
Similar to the predication with Serotonin, it is unclear from this title
that [Magnesium INHIBITS Vasoconstriction] as noted by Swanson.
On the other hand, the article [PMID1153064] by Domzal, from
which the predication [Migraine Disorders ISA Vascular Diseases]
was extracted (among three others), suggests that migraine is also
Fig. 11. Subgraph4 ðk ¼ 2;2rÞ magnesium – migraine.
Fig. 12. Subgraph9 ðk ¼ 2;2rÞ magnesium – migraine.
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article [PMID3945397] by Coppeto et al. from which the predica-
tion [Migraine Disorders AFFECTS Vascular Diseases] was extracted
provides more compelling evidence by linking migraine and vascu-
lar retinopathy as suggested by Swanson. Coppeto reported that
‘‘two migraineurs suffered sudden, persisting loss of vision from retinal
vascular occlusion.’’ This effect is consistent with the observation by
Houston et al. from the article [PMID3512233] on Serotonin from
subgraph1. Salati et al. in [PMID6225285], from which the predica-
tion [Migraine Disorders ISA Vascular Diseases] was extracted, noted
a dependency among Migraine, Vascular diseases, Epilepsy, and
Autoscopy (outer-body hallucination).
The two calcium channel blockers, Nifedipine and Verapamil
were the only intermediates in subgraph22 (not shown). All three
articles [PMID2425960, PMID3673084, PMID6539877] conﬁrmed
that these calcium channel blockers treat Migraine as suggested
by Swanson. The article [PMID537283] by Khoda et al. from which
the predication [Verapamil INTERACTS_WITH Magnesium] was
extracted suggested that Magnesium inhibits Verapamil as noted
by Swanson.
The intermediate Hydrocephalus (accumulation of ﬂuid in the
brain), which leads to Brain Edema (referred to as Inﬂammation
by Swanson), was found among the zero-rarity associations (see
Table 3). The remaining intermediates Hypoxia, Spreading Cortical
Depression, Stress (Type A Personality), and Substance P were not
found among the subgraphs.
Interestingly, only subgraph22 on the calcium channel blockers
was a complex subgraph in which existing knowledge was recov-
ered. While several intermediates related to Vascular Reactivity,
such as Vasospasm, Vascular Function, Vasoconstriction, and
Vascular Disease exists, their shared context did not meet our
threshold for path relatedness and hence they were not grouped
into the same cluster. The shortcomings of SemRep in extracting
Vascular Reactivity may also have been a limiting factor. Still, alto-
gether 10 out of the 25 subgraphs contained complex associations.Subgraph7 (shown in Fig. 13) for example, links Theophylline
and Caffeine, with Magnesium and Migraine, which have different
semantic types, but belong to the general group of Stimulants.
Subgraph6 (not shown) associates Epinephrine and Glucose from
the perspective of Metabolism. Table 3 shows that ultimately, 7
out of the 11 associations found by Swanson could be found using
our approach.
4.1.3. Somatomedin C – Arginine
In April 1989, Swanson explored the research question of the
role of the dietary amino acid Arginine and the protein
Somatomedin C (also called Insulin-Like Growth Factor 1 (IGF1)) in
Growth. Through the methods discussed in [16], Swanson discov-
ered 4 implicit connections between Somatomedin C and Arginine.
He found that Arginine intake could: (1) stimulate Growth and pro-
tein synthesis, (2) promote Wound Healing and cell regeneration,
(3) facilitate nutritional repletion and overcome Malnutrition, and
(4) improve Body Mass (and Weight), especially in the elderly
and debilitated.
We seeded our algorithm with Somatomedins (C0037657) and
Insulin-Like Growth Factor I (C0021665) as the sources, and
Arginine (C0003765) as the target. The corpus consisted of more
than 11,000 articles (819) on Somatomedins and 10,698 on
Arginine (with 53 overlapping), in the pre-April 1989 period. The
path length was set to 2, and the STRICT predicate ﬁlter was used
to eliminate non-informative predicates. There were 5195 con-
cepts and 17,058 predications in the predications graph and 239
distinct paths in the candidate graph. The algorithm terminated
in less than one hour producing 10 subgraphs (and 153 singletons)
at 2r and 7 subgraphs (and 205 singletons) at 3r.
Fig. 14 shows the intermediate Growth Hormone in subgraph5 at
3r. The sequence of predications [Arginine STIMULATES Growth
Hormone] and [Growth Hormone STIMULATES Somatomedins] is
entirely correct and requires no further proof (in terms of rediscov-
ery). Still, for veriﬁcation, we conﬁrmed in the article
[PMID6394628] by Chew et al. that dietary Arginine stimulates
the release of Growth Hormones. These Growth Hormones then sti-
mulate the production of Somatomedin C (IGF1), which leads to cell
growth and increased body size andmuscle (i.e., protein synthesis),
as noted in article [PMID7194347] by Clemmons et al. The same
association is captured in subgraph6 at 2r (not shown).
In subgraph5, several articles from which the seemingly spuri-
ous predication [Arginine TREATS Child] was extracted, upon inves-
tigation, were shown to actually discuss Glucagon and Insulin. This
includes the article [PMID7204541] by Blethen et al. whose title is
‘‘Plasma somatomedins in children with hyperinsulinism.’’ Likewise,
the article [PMID6205015] by Binoux et al. fromwhich the predica-
tion [Arginine TREATS Rattus norvegicus] was extracted, discusses
observations regarding Insulin-like Growth Factor 1 in the serum
of rats. The article [PMID7007553] by Ashby et al. from which
the same predication was extracted, discusses the effects of
Progesterone and Insulin in rats, resulting from Glucose and
Arginine stimulation. Based on these observations, it is reasonable
to conclude that this subgraph captures the shared context of role
of Insulin with Somatomedin C and Arginine.
Subgraph7 at 3r (not shown) contains the concept Growth as an
intermediate instead of Growth Hormone (similar to subgraph2 at
2r, also not shown). The sequence of predications [IGF1 CAUSES
Growth] and [Growth PRODUCES Somatomedins] is interesting
because the article [PMID3748655] by van Buul-Offers et al. from
which the predication [IGF1 CAUSES Growth] was extracted states
that IGF1 ‘‘increases body length and weight, as well as the growth
of several organs of Snell dwarf mice,’’ which is consistent with
Swanson’s report. The association between Malnutrition and
Somatomedin production was found in the article [PMID7023246]
by McCumbee et al., from which the predication [Growth
Table 3
Comparison of rediscoveries with other approaches for magnesium – migraine.
Scenario Intermediate(s) Cameron Srinivasan [7] Weeber [4] Blake [37] Gordon [3]
S P S P S P S P S P
Magnesium – migraine Calcium channel blockers Y 22 Y 3 Y – Y 10 Y 1
Epilepsy Y⁄ 9 – – Y – Y 8 Y 3
Hypoxia – – Y 5 – – Y 6 Y 77
Inﬂammation Y⁄ ZR-3 Y 2 Y – Y 170 Y 82
Platelet activity Y⁄ 1 Y 2 Y – Y 2 Y 8
Prostaglandins Y 4 Y 1 Y – Y 42 Y 27
Stress/Type A personality – – Y 1 Y – Y 23 – –
Serotonin Y 1 Y 1 Y – Y 5 Y 1
Spreading Cortical Depression – – Y 6 – – Y 45 – –
Substance P – – Y 18 Y – Y 38 Y 23
Vascular mechanisms Y 9 Y 1 Y – Y 46 Y 16
Fig. 13. Subgraph7 ðk ¼ 2;2rÞ magnesium – migraine.
Table 4
Comparison of rediscoveries with other approaches for somatomedin C – arginine.
Scenario Intermediate(s) Cameron Srinivasan [7]
S P S P
Somatomedin
C – arginine
Growth hormone Y 5 Y 1
Body weight Y⁄ 7 Y 4
Malnutrition Y⁄ 7 – –
Wound healing – – Y 4
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to Wound Healing was found using our methods. Table 4 shows
that 3 out of 4 intermediates could be found using our approach.4.1.4. Remaining experiments
This section brieﬂy presents the results for the remaining 6
rediscoveries attempted.
Scenario 4: For the Indomethacin – Alzheimer’s Disease discovery
[12] by Smalheiser and Swanson in 1995, there were 15 subgraphs
at 2r. Srinivasan found all 8 intermediates, while we only recov-
ered 6 out of 8 intermediates from subgraphs 2, 3, 4, and 14
(shown in Table 5).
Scenario 5: For Estrogen – Alzheimer’s Disease [13] by
Smalheiser and Swanson in 1995, we found 3 out of 8 intermedi-
ates from 3 subgraphs at 2r, as shown in Table 6. Srinivasan did
not attempt this experiment (see Table 7).Fig. 14. Subgraph5 ðk ¼ 2;3rÞ SScenario 6: For Calcium-Independent PLA2 – Schizophrenia [14]
by Smalheiser and Swanson in 1997, our algorithm produced 10
subgraphs at 2r, all of which were singletons. Here, our results
are comparable to Srinivasan’s, except that we are able to retrieve
the article [PMID7782894] by Kuo et al. deemed crucial to the dis-
covery, through discovery browsing from singleton2. The seeming-
ly innocuous singleton in subgraph2 (not shown), which states that
[Phospholipase A2 INHIBITS Proteins] [Proteins CAUSES Schizophrenia]
leads to the article [PMID7739414] by Berry, from which the
predication [Proteins CAUSES Schizophrenia]was extracted. The arti-
cle shows that the speciﬁc protein discussed was the selenium
transport protein Selenoprotein P, as noted by Smalheiser. The article
by Kuo is #4 in the search results of a MEDLINE search for
Phospholipase A2 AND Selenium AND 1865:1997[DP].
Scenario 7: For Chlorpromazine – Cardiac Hypertrophy [29] by
Wren et al. in 2002, there were 14 subgraphs at 2r. The interme-
diate Isoproterenol was found in subgraph12 (as shown in
Table 8). The article [PMID6165961] by Rossi et al. from which
the predication [Chlorpromazine INHIBITS Isoproterenol] was
extracted, together with the article [PMID203365] by Tsang et al.omatomedin C – arginine.
Table 5
Comparison of rediscoveries with other approaches for indomethacin – Alzhiemer’s
disease.
Scenario Intermediate(s) Cameron Srinivasan
[7]
S P S P
Indomethacin –
Alzheimer’s disease
Acetylcholine Y 4 Y 2
Lipid peroxidation Y⁄ 2 Y 4
M2-muscarinic – – Y 3
Membrane Fluidity – – Y 10
Lymphocytes Y⁄ 14 Y 4
Thyrotropin Y ZR-
20
Y 9
T-lymphocytes
(T-Cells)
Y⁄ 3 Y 5
Table 7
Comparison of rediscoveries with other approaches for calcium-independent PLA2 –
schizophrenia.
Scenario Intermediate(s) Cameron Srinivasan
[7]
S P S P
Calcium-independent
PLA2 – schizophrenia
Oxidative
stress
Y⁄ 3 Y 3
Selenium Y⁄ 3 – –
Vitamin E Y⁄ 3 – –
Table 8
Comparison of rediscoveries with other approaches for chlorpromazine – cardia
hypertrophy.
Scenario Intermediate(s) Cameron
S P
Chlorpromazine – cardiac hypertrophy Calcineurin Y 5
Isoproterenol Y 12
9 eUtils Help – http://www.ncbi.nlm.nih.gov/books/NBK25500/.
Table 6
Comparison of rediscoveries with other approaches for estrogen – Alzheimer’s
disease.
Scenario Intermediate(s) Cameron
S P
Estrogen – Alzheimer’s disease Antioxidant activity Y⁄ 4
Alipoprotein E (ApoE) Y⁄ 3
Calbindin D28k Y 4
Cathepsin D – –
Cytochrome C oxidase – –
Glutamate – –
Receptor polymorphism – –
Superoxide dismustase – –
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was extracted, substantiated these predications. Subgraph5 con-
tained the predication [Chlorpromazine INHIBITS Calcineurin]
extracted from the article [PMID9001710] by Gong et al. and the
predication [Calcineurin CAUSES Cardiac Hypertrophy] extracted
from several articles, including [PMID9568714, PMID10679475,
PMID11248077, PMID11773940, PMID10189350] (see Table 9).
Scenario 8: For Testosterone – Sleep [30] by Miller and
Rindﬂesch in 2011, which articulates that ‘‘testosterone enhances
sleep quality by inhibiting cortisol,’’ we found 11 subgraphs at 2r
and 10 subgraphs at 3r. Cortisol (or Hydrocortisone) was found in
subgraph7 at 3r and also in subgraph11 at 2r. The article
[PMID8548511] by Kern et al. conﬁrmed that [Hydrocortisone
DISRUPTS Sleep], while the crucial article [PMID15841103] byRubinow et al., noted by Miller, conﬁrms that [Testosterone
INHIBITS Hydrocortisone].
Scenario 9: For Diethylhexyl Phthalate (DEHP) – Sepsis [28] by
Cairelli and Rindﬂesch in 2013, which articulates one possible
mechanism for the obesity paradox [55], we did not ﬁnd the inter-
mediate PParGamma altogether. In our retrospective analysis, we
found that the novel intermediate PParGamma was present in the
predications graph, but not in the candidate graph. This is because
no direct links between PParGamma and Sepsis existed in the can-
didate graph – consisting of paths of length 3 between DEHP and
Sepsis. In the predications graph the predication, which states that
[DEPH STIMULATES PParGamma] was present (extracted from
[PMID22953781, PMID16326050]). We also noticed predications
between PParGamma and Liver, Genes, STAT5A gene, etc. However,
none of these concepts were linked directly to Sepsis. These obser-
vations suggest that the path length speciﬁed is perhaps too short.
It also suggests that additional concepts, related to Sepsis (as termi-
nals) may be necessary.
In summary, several approaches succeed in providing automa-
tion for ﬁnding intermediates. These approaches leverage key-
word-based, concept-based relations-based, graph-based and
hybrid techniques.Many also provide predicates between concepts,
while more recent approaches are able to substantiate intermedi-
ates with provenance in MEDLINE. The main innovation of our
approach is that we are able to retrieve and substantiate existing
discoveries, on different thematic dimensions, using implicit and
explicit semantics as suggested by Gordon andDumais [32], not fre-
quency, graph metrics or speciﬁcity. To the best of our knowledge,
an approach that has rediscovered as many intermediates, with
suchdegree of automation and substantiation has never been devel-
oped. In the next section the statistical evaluation is presented.
4.2. Statistical evaluation
In the previous section, we showed that our context-driven,
automatic subgraph creation method facilitated the rediscovery
of 8 existing discoveries with their substantiation in MEDLINE.
While these are encouraging results, one might argue that our
experiments were biased since we knew the intermediates to be
found in the ﬁrst place. Hence, it was easy to ﬁnd them in the sub-
graphs. A more important question is how interesting are subgraphs
in general, such that an arbitrary domain expert might be motivated to
explore them altogether? To address this question, we conducted a
statistical evaluation, which uses association rarity to compute
interestingness. If the interestingness score of the subgraphs across
an entire experiment is low, then the rediscoveries were fortuitous
and the associations that led to the rediscoveries were serendipi-
tous, rather than systematic. While this not a complete loss, it is
still less than ideal.
To perform this evaluation, for each path in each subgraph
across the 8 rediscoveries (excluding singletons), a PubMed query
was executed using the eUtils Web Service.9 This was used to deter-
mine the number of documents that contain the association in
MEDLINE, with the date restriction enforced. For example, for the
path [Arginine STIMULATES Growth Hormone], [Growth Hormone
STIMULATES Somatomedins], the query ‘‘Arginine AND Growth
Hormone AND Somatomedins AND 1865:1989/04[DP]’’ was composed,
where Arginine, Growth Hormone, and Somatomedins represent an
association. The rarity
rðEÞ ¼
P
pi2Ef ðAðpiÞÞ
jEj ð10Þ
Table 9
Comparison of rediscoveries with other approaches for testosterone – sleep.
Scenario Intermediate(s) Cameron Goodwin [21]
S P S P
Testosterone – sleep Cortisol/hydrocortisone Y 10 Y 4
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computed as the average of the association rarity, where f ðAðpiÞÞ
is the frequency of a unique association AðpiÞ from path pi in
MEDLINE. The interestingness
IðEÞ ¼ 1
rðEÞ þ 1 ð11Þ
of an experiment E is computed as the normalized reciprocal of its
rarity.
Table 10 shows the rarity and interestingness scores for each of
the eight successful rediscoveries. For the Raynaud Syndrome –
Dietary Fish Oils experiment, there were 10 unique intermediates/
associations among the 4 subgraphs at 2r; each of which had a
zero-rarity in MEDLINE. This is not surprising, since Swanson noted
in [1] that only four articles from the Raynaud literature overlapped
with the Fish Oil literature by 1986. The rarity of these subgraphs is
therefore 0.00, and the interestingness is 1 (meaning absolutely
interesting).
For Magnesium – Migraine there were 48 unique intermediates/
associations, across a total of 27 documents (Table 10, row 3). The
most commonly known intermediates were Hypertensive Disease
(3), Individual (3), and Vascular Diseases (4) respectively. The overall
rarity of the subgraphs in the experiment is therefore 27/48 = 0.56
and the interestingness is 0.64 (i.e., somewhat interesting).
For Somatomedin C – Arginine there were 18 unique intermedi-
ates/associations across a total of 306 documents (Table 10, row 4).
The most commonly known intermediates were Child (16),
Somatropin (63), and Growth Hormone (63). There were only two
zero-rarity associations, which were from the intermediates Mus
(0) and Falls (0). Clearly these are not interesting. Not surprisingly,
the overall rarity score of these subgraphs is 306/18 = 17 and their
interestingness is low (0.06). These high association frequencies
suggest that perhaps the ﬁeld is more well-studied. It also partially
supports the observation by Gordon and Dumais [32] that while
frequency of intermediates may be sufﬁcient for ﬁnding novel
intermediates in some cases, it may be insufﬁcient to capture the
related concepts that elucidate complex associations.
For Indomethacin – Alzheimers there were 21 unique associations
across a total of 9 documents (Table 10, row 5). Hydrogen Peroxide
(2), Interleukin-1 (2) and Free Radicals (3) were the most commonly
known intermediates. The overall rarity score is 9/21 = 0.43 and the
interestingness is 0.70 (i.e., quite interesting).
For Estrogen – Alzheimers there were 42 unique associations
across a total of 36 documents (Table 10, row 6), among which
36 were zero-rarity associations. Metabolism (6), Dementia (10),Table 10
Rarity and Interestingness score of the subgraphs in the rediscoveries.
Experiment #Unique associations
Raynaud syndrome – dietary ﬁsh oils 10
Magnesium – migraine 48
Somatomedin C – arginine 18
Indomethacin – Alzhiemer’s disease 21
Estrogen – Alzhiemer’s disease 42
Calcium independent PLA2 – schizophrenia 10
Chlorpromazine – cardiac hypertrophy 21
Testosterone – sleep 61
Average 29and Senile dementia (10) were the most commonly known interme-
diates. The rarity score is 36/42 = 0.86 and the interestingness is
0.54.
For Calcium-Independent PLA2 – Schizophrenia there were 10
unique intermediates/associations (singletons described in
Section 4.1.6), each of which was zero-rarity. Hence, the rarity of
this subgraph is 0.00 and the interestingness was high (1.0).
For Chlorpromazine – Cardiac Hypertrophy there were 21 unique
intermediates/associations across a total of 2 documents (Table 10,
row 8) and 19 at zero-rarity. The most commonly known were
Catecholamines (1) and Hypertensive disease (1). The rarity is there-
fore 2/21 = 0.10 and the interestingness is high (0.91).
For Testosterone – Sleep, there were 61 unique intermediates/as-
sociations across a total of 654 documents (Table 10, row 9) and 20
at zero-rarity. The most commonly known were Proteins (63),
Symptoms (91), and Hormones (207). The overall rarity score is
therefore 654/61 = 10.72 and the interestingness is low (0.09).
This is not surprising, since these two domains (Testosterone and
Sleep) are fairly well studied.
Across all 8 rediscoveries, the average rarity score is therefore
3.71 and the average interestingness is 0.62. This suggests that
an association chosen at random from the rediscoveries is likely
to be known to only approximately 4 documents in MEDLINE.
Such a low rarity score suggests that the subgraphs themselves
might be quite interesting to a domain expert. This is however
not surprising, since most of the discoveries, at the time when
made would have been inherently interesting situations and possi-
bly not well studied in the literature. Testosterone – Sleep (2011)
and Somatomedin C – Arginine (1990) are exceptional.5. Discussion
This paper showed that the use of implicit and explicit seman-
tics to ﬁnd and elucidate associations among concepts along mul-
tiple thematic dimensions can be effective for LBD. Another
important contribution is that domain scientists can infer relation-
ships not explicitly stated in the subgraphs, based on meaningfully
connected semantic predications. Our overall approach however,
has several limitations. The ﬁrst limitation is the assumption that
the context of a semantic predication, expressed in terms of the
distribution of MeSH descriptors is reliable for generating mean-
ingful subgraphs. Not all MeSH descriptors assigned to an article
are relevant to all its semantic predications, and hence the predica-
tion context vectors could be noisy. Ideally, direct mappingsMEDLINE frequency r(E) I(E)
0 0.00 1.00
27 0.56 0.64
306 17.00 0.06
9 0.43 0.70
36 0.86 0.54
0 0.00 1.00
2 0.10 0.91
654 10.72 0.09
129 3.71 0.62
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resolve this discrepancy. Since, such mappings are unavailable
our speciﬁcation of context is subject to limitations of distribution-
al semantics.
The second limitation is the degree of domain expertise still
required for discovery browsing. Although impractical to eliminate,
one improvement could be providing additional background
knowledge to supplement the subgraphs where appropriate. In this
way, assertional knowledge from the literature would be comple-
mented with deﬁnitional knowledge from structured knowledge
sources (though deep integration). Metrics for determining inter-
esting neighboring concepts in background knowledge need to be
developed for concepts in the subgraph to overcome this limitation.
Another limitation is the inability to systematically detect con-
tradicting semantic predications. While the provenance of predica-
tions in MEDLINE allows domain experts to adjudicate, a method
for resolving conﬂicting predications would be beneﬁcial. We
believe that temporal analysis of semantic predications could
enable conﬂict resolution. However, since many unresolved para-
doxes inherent in science itself are reported in the literature, it is
unclear whether one might reliably detect and resolve such contra-
dictions automatically, using temporal, statistical and/or semantic
approaches.
The reliability of the statistical evaluation is also another limita-
tion of our approach. Rare associations are generally interesting
but not always. While alternative methods for conducting statisti-
cal evaluation for LBD have been discussed [56], it is cumbersome
to coordinate cut-off dates for each predication across the redis-
coveries. The suggested techniques are therefore impractical to
implement. We use association rarity to indicate interestingness,
similar to existing research [45,36].
A number of technical limitations exist in our approach. The
ﬁrst technical limitation is the manual selection of a threshold
for MeSH semantic similarity based on dice similarity. While dice
is advantageous because it is easy to implement, other similarity
metrics and more principled ways of computing the threshold
should be explored. Likewise, the threshold for path relatedness,Fig. A.15. Screenshot of thewhich is based on the second (and third) standard deviation from
the mean of the Gaussian distribution, could be unreliable. Our
results show that the data distributions only approximate to
Gaussian. The p-values from the v2 test of the three Gaussian dis-
tributions in Fig. 4 are indeed more than the 0.05 value normally
considered reliable. To overcome this limitation, we anticipate that
path relatedness could be recomputed relative to the minimum
relatedness score. Torvik et al. [40] and Smalheiser et al. [42]
implemented an approach based loosely on this idea, which nor-
malized the distribution, using a mixture of Gaussian models.
Across some experiments, we utilized predicate ﬁlters to elim-
inate non-informative relationships (such as ASSOCIATED_WITH,
INTERACTS_WITH, AFFECTS, etc). This is a compromise to achieve scalabil-
ity. Ideally, the system should not require any predicate ﬁlters. In
fact, the omission of some predicates may be responsible for low
recall in some of our experiments. Still, given that most experi-
ments terminated in less than one hour, higher recall may not be
too costly for performance. With the emergence of big data infras-
tructure, the performance limitations of our clustering may be
resolved using alternative platforms, such as Apache Spark.
The choice of HAC could be considered another limitation. HAC
was selected because it is an unsupervised, deterministic clustering
algorithm, for which the number of clusters does not have to be
known or speciﬁed a priori. The time complexity of HAC is
OðN2 logNÞ in the best case. While approaches, such as those by
Ramakrishnan et al. [45] and van der Eijk et al. [47] may be applica-
ble for subgraph creation, it is unclear how theymight be adapted to
generate complex subgraphs along multiple thematic dimensions.
These and other limitations suggest the next steps in this
research. In future, labels for subgraphs should be provided. This
is a crucial task, since our approach is predicated on the idea that
each subgraph captures a different thematic dimension of asso-
ciation between two concepts. Additionally, a comparative study
using full text, against titles and abstracts, could be useful. Since,
full text is only available on a limited scale, this is not a straightfor-
ward task.Obvio web application.
156 D. Cameron et al. / Journal of Biomedical Informatics 54 (2015) 141–1576. Conclusion
Leveraging rich representations of textual content from scien-
tiﬁc literature based on implicit and explicit context can provide
effective means for literature-based discovery, as illustrated in this
paper. These rich representations facilitated the rediscovery of 8
out of 9 well-known discoveries and their substantiation. Our
approach is therefore an advancement of LBD research since it
illustrates that notions of context and shared context can be
important for making discoveries from scientiﬁc literature, which
do not rely on statistical frequency, graph metrics or speciﬁcity.
A beta-version of the Obvio web application, which showcases
the rediscoveries, is available online for optional viewing (http://
knoesis-hpco.cs.wright.edu/obvio/), along with various other
resources (wiki page – http://wiki.knoesis.org/index.php/Obvio,
video demo – http://bit.ly/obviodemo), which help put the contri-
butions of this research into perspective. Further details about each
experiment are also given in [54].
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Appendix A. The Obvio web application
This Appendix describes the Obvio web application (shown in
Fig. A.15) developed to showcase the rediscoveries. The system
consists of 11 components, which can be used to explore sub-
graphs generated for closed discovery scenarios, using the follow-
ing steps.
Step 1: The user must ﬁrst select a start term (A) using compo-
nent 1. For example, the concept Chlorpromazine can be selected
as an A-term.
Step 2: The user must then select the target term (C) using com-
ponent 2. For example, the concept Cardiac Hypertrophy has
been selected as the target term, for the given source.
Step 3: The user must then select the ‘Search’ button to submit
the search request. Obvio retrieves the metadata for the search
terms, which are then displayed in the ‘metadata panel’ imme-
diately below search terms (component 3).
Step 4: The identiﬁers of the preprocessed subgraphs are shown
in the ‘subgraph panel’ in component 4.
Step 5: The user must then select the identiﬁer of a subgraph
from the subgraph panel. The corresponding subgraph will be
displayed in the ‘viewer’ (component 5).
Step 6: Interesting semantic predications may then be explored
by clicking on the edge between concepts of interest in the
viewer.
Step 7: The number of MEDLINE articles that contain the visu-
alized semantic predications is shown the ‘Result Metadata
Panel’ (component 6). The identiﬁer for the MEDLINE article is
also shown (currently shown, 2000 Feb 18). The title of the arti-
cle is shown in component 7, while the date of publication is
shown in component 8. The selected semantic predication isshown in component 9 (currently shown, Calcineurin-CAUSES-
Cardiac Hypertrophy). The set of MEDLINE articles that contain
the predication are also available for inspection in component
10. More importantly, the sentence from which the semantic
predication was extracted will be highlighted.
Step 8: The user may also utilize the functionality from the
‘Filtering panel’ in component 11, to view different perspectives
in the subgraphs based on semantic types and groups. Note that
the original subgraph can be restored by clicking an arbitrary
point in the viewer. Also, when any node in the subgraph has
been selected, only the inlinks and outlinks connected to the
selected node are displayed.References
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